Hawkins Reports Record Fiscal 2025 Sales of $974.4 Million and Diluted EPS of $4.03
Hawkins reported record fourth-quarter and full-year fiscal 2025 results, with full-year sales up 6% to $974.4 million and diluted EPS up 12% to $4.03. The company expects all segments to grow in fiscal 2026 and revenue to surpass $1 billion, but expects EPS growth to slow due to higher interest and amortization expense.
Key points
- Fourth-quarter sales rose 10% to $245.3 million and diluted EPS rose to $0.78 from $0.66 a year earlier.
- Full-year Water Treatment sales rose 23% to $446.5 million, while Industrial sales fell 7% and Health and Nutrition sales fell 1%.
- Net debt ended the year at $143.9 million, with a leverage ratio of 0.86x adjusted EBITDA; the company expects it to fall below 1x by the end of fiscal 2027.
- Fiscal 2026 EPS is expected to grow more slowly than in recent years, and the company will report under new segments starting in the first quarter of fiscal 2026.
The filing
Written by AI on Nov 8, 2026, 1:49 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 14, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.